Consultant and Chair of the Metabolic Bone Disease Core Group in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic.
He obtained his medical degree from the University of California, Los Angeles
Geffen School of Medicine in 1986. After completing his residency in internal
medicine and fellowship in endocrinology and metabolism at the Mayo
Graduate School of Medicine in 1992, he completed further fellowship
training in bone and mineral metabolism. His current clinical research
interests include serotonin skeletal effects, postmenopausal osteoporosis,
new anabolic therapies, glucocorticoid- and transplantation-induced
osteoporosis, tumor-induced osteomalacia, primary hyperparathyroidism,
hypoparathyroidism, and biomechanical effects on the skeleton.
Professor John Wass (MA, MD, FRCP)
Professor of Endocrinology at Oxford University and the Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, UK until 2012.
Since 1975 he has published over 385 articles in scientific journals and as
well as written many reviews and chapters in textbooks including the
Oxford Textbook of Medicine. He was the President of the European
Federation of Endocrine societies from 2001 -2003 and was the Chairman
of the Society for Endocrinology (2006-2009). He has won a number of
prices including the Lifetime Achievement Award by the Pituitary Society of
USA and the distinguished Physician of the Year 2015, awarded by the
American Endocrine Society; being the first non-American to ever receive
Professor William F. Young, Jr. (MD, MSc)
Professor of Medicine at Mayo Clinic College of Medicine. Chair, Division of Endocrinology, Diabetes, Metabolism, and Nutrition Mayo Clinic College of Medicine, Rochester, Minnesota USA
William F. Young, Jr., MD, MSc, received his MD degree in 1978 from Michigan State
University. He is the recipient of multiple education awards. In 2010 he received a
named professorship—the highest academic distinction at Mayo Clinic. Dr. Young’s
clinical research focuses on primary aldosteronism and pheochromocytoma. He has
published more than 210 articles on endocrine hypertension and adrenal and
pituitary disorders. He has presented at over 250 national and international
meetings and he has been an invited visiting professor at more than 100 medical
institutions. He was president of the Society from 2012 to 2013 and remains actively
involved with various educational activities
Mr. Simon Cudlip (MBBS, BSc (Hons), MD FRCS (Eng), FRCS (Neurosurgery))
Consultant Neurosurgeon and Spinal Surgeon and Head of Department Oxford University Hospitals, Oxford, United Kingdom.
Simon Cudlip Graduated King’s College School of Medicine, London
in 1990. During this period, he also gained a BSc first class (Hons) in
immunology. In 2004 he was appointed as Consultant in
Neurosurgery with a specialist interest in pituitary and skull-base
surgery in Oxford, and Honorary Senior Lecturer in Neurosurgery at
the University of Oxford. Since this time, he has performed over 1200
transsphenoidal operations for pituitary disease, these have been
performed using a pure endoscopic technique since 2007. As a result
of this Oxford has the best established nationally recognized
pituitary surgical training fellowship in the UK
Professor David Stephen Cooper (M.D)
Professor of Medicine at the Johns Hopkins University School of Medicine and Professor of International Health at the Bloomberg Johns Hopkins School of Public Health.
He serves as an Editor In-Chief for Endocrinology for Up-to-Date, as a
Contributing Editor of the Journal of the American Medical
Association (JAMA), and as the Deputy Editor of the Journal of Clinical
Endocrinology and Metabolism. He is the Chair of the Subspecialty
Board for Endocrinology, Diabetes, and Metabolism of the American
Board of Internal Medicine. Dr. Cooper is the past President the
American Thyroid Association, and the recipient of the American
Thyroid Association Distinguished Service Award.
Professor Margaret E. Wierman (M.D)
Professor of Medicine, Physiology and Biophysics, Chief of Endocrinology, Denver VAMC.
Dr. Wierman received her MD and residency training at Baylor College of
Medicine. Her fellowship and research training was at Massachusetts General
Hospital and the Brigham and Women’s Hospital at Harvard University.
She has been a faculty member at the University of Colorado since 1987 and her
expertise is in reproductive and neuroendocrinology. Dr. Wierman’s research
interests are in the regulation of the genes that control the reproductive axis.
Dr. Wierman chaired the Endocrine Society Task Force on the role of Androgens
in Women. She has also served on and chaired multiple NIH Study Sections
including the Population Research Subcommittee, the Specialized Programs in
Reproduction and the Integrative Clinical Endocrinology and Reproductive Section
and served on the Endocrine and Metabolic Drugs panel for the FDA. She received
the 2009 Sydney H. Ingbar Distinguished Service Award, given in recognition of
distinguished service in the field of Endocrinology
Professor Paul Hofman (MbChB, Dip Obs, FRACP)
Professor Hofman is a clinical endocrinologist and researcher based at the Liggins Institute, University of Auckland.
Professor Hofman has been involved in clinical research for over 25 years and has
published more than
160 papers. His major interests include the developmental origins of adult health
and disease, and the impact of prenatal under and over nutrition in children,
including those born small for gestational age, preterm, post term and large for
gestational age. He is also interested in underlying causes of obesity, obesity
interventions and screening outcomes in the new born. Professor Hofman assists
numerous support groups including the Turner Syndrome society, the CAH society
and the Prader- Willi Society.
He is also involved in an international group of endocrinologists aiming to improve
paediatric endocrine care, in resource constrained countries in the Asia Pacific
Professor Marta Korbonits ( MD, PHD )
Professor of Endocrinology and Metabolism and Centre Lead for Endocrinology at Barts and the London School of Medicine and Dentistry, Queen Mary University of London UK.
Márta Korbonits graduated in Medicine in Budapest and undertook her early
clinical training at the Internal Medicine Department of the Postgraduate
Medical School, Budapest. Her MD and later PhD studies contributed to the
understanding of the effects of growth hormone secretagogues on
hypothalamic hormone release and the nature and causes of pituitary
tumorigenesis. She was awarded an MRC Clinician Scientist Fellowship, and
commenced studies that produced novel insights into ghrelin physiology and
Professor André Lacroix ( M.D., FCAHS )
Professor, Department of Medicine, Division of Endocrinology Research Center, Centre hospitalier de l’Université de Montréal (CHUM)
Prof. Lacroix completed M.D. degree in 1972 and specialization in endocrinology in 1977 at Université de
Montréal. Since 1980, he has been Director of Endocrine Pathophysiology laboratory at Institut de Recherches
Cliniques de Montréal (IRCM) until 1992 and now at the CHUM Research center (CRCHUM). He served as chief
of Endocrine Division at Hôtel-Dieu hospital and as Director of the Endocrinology Training Program of
Université de Montréal. He was Chairman of the Department of Medicine from 2002-2008 and Associate
Director General for Medical and Academic Affairs at CHUM (2008-2012). He served as president of the
Canadian Society of Endocrinology and Metabolism (2005-2007) and on the executive board of the
International Society of Endocrinology (2010-16) and is currently chairperson of ISE (2016-20).
He is currently co-editor of the Adrenal Section of UpToDate (Boston, MA) and Encyclopedia of Endocrinology
(Elsevier), Associate Editor of the European Journal of Endocrinology. He received the Medical Leadership
award from CHUM Foundation in 1999 and the Robert Volpé 2010 award from CSEM in recognition for his
contributions to Endocrinology in Canada. He was elected Fellow of the Canadian Academy of Health Sciences
in 2008 and foreign member of the National Academy of Medicine of France in 2016. His Major Areas of
research interests are Molecular and genetic mechanisms of adrenal tumors and hyperplasias leading to
Cushing’s syndrome, primary aldosteronism and adrenal tumorigenesis. Role of aberrant adrenal hormone
receptors in adrenal over function. New drugs in the therapy of Cushing’s disease and primary aldosteronism,
of adrenocortical cancer and pheochromocytomas.
Prof. Andrew JM Boulton (MD, DSc (Hon), FACP, FICP, FRCP)
Consultant Physician, Manchester Royal Infirmary, President , Worldwide Initiative for Diabetes Education, Chair, EURADIA: Alliance for European Diabetes Research, President-Elect, International Diabetes Federation, Professor of Medicine, University of Manchester.
Professor S. Faisal Ahmed
Samson Gemmell Chair of Child Health, Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Scotland, UK.
Dr. Manodhi Saranapala,
MBBS, MD, MRCP, FRACP, Australia
Dr. Agustini Utari (MSi. Med, Sp.A(K))
Pediatric Endocrinologist, Diponegoro University, Semarang, Indonesia.
Dr. Lalantha Leelarathna (PhD)
Consultant Diabetologist and Honorary Senior Lecturer, Manchester Diabetes Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust / University of Manchester, Hathersage Road, Manchester, United Kingdom
Dr. Mujahid Saeed (MBBS, MRCP (UK) (Endocrinology and Diabetes), FRCP (UK), AHEA)
Consultant Physician in General Medicine and Diabetes (Consultant Physician and Diabetologist), Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, NHS Foundation Trust, UK
Dr. Ruby Mahesparan
Senior Consultant, Head of Neurosurgery, Department at Haukeland, Hospital in Bergen, Norway.
Dr. Siva Sivapriyan
Endocrinologist & Honorary Senior Lecturer King's College London, Clinical Governance Lead Maidstone, Maidstone Hospital, England